Abstract
Significant progress has been made in our understanding of the mechanisms leading to autoimmune thyroid diseases (AITD). For the first time, we are beginning to unravel these mechanisms at the molecular level. AITD, including Graves’ disease (GD) and Hashimoto’s thyroiditis (HT), are common autoimmune diseases affecting the thyroid. They have a complex etiology that involves genetic and environmental influences. Seven genes have been shown to contribute to the etiology of AITD. The first AITD gene discovered, HLA-DR3, is associated with both GD and HT. More recently, this association was dissected at the molecular level when it was shown that substitution of the neutral amino acids Ala or Gln with arginine at position beta 74 in the HLA-DR peptide binding pocket is the specific sequence change causing AITD. Non-MHC genes that confer susceptibility to AITD can be classified into two groups: (1) immune-regulatory genes (e.g., CD40, CTLA-4, and PTPN22); (2) thyroid-specific genes—thyroglobulin and TSH receptor genes. These genes interact with environmental factors, such as infection, likely through epigenetic mechanisms to trigger disease. In this review, we summarize the latest findings on disease susceptibility and modulation by environmental factors.
Similar content being viewed by others
References
Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y (2008) Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 29:697–725
Jacobson DL, Gange SJ, Rose NR, Graham NM (223) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223–243
Weetman AP (2000) Chronic autoimmune thyroiditis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The thyroid. Lippincott Williams and Wilkins, Philadelphia, pp 721–732
Menconi F, Oppenheim YL, Tomer Y (2008) Graves' disease. In: Shoenfeld Y, Cervera R, Gershwin ME (eds) Diagnostic criteria in autoimmune diseases. Humana Press, Totowa, NJ, pp 231–235
Gebe JA, Swanson E, Kwok WW (2002) HLA class II peptide-binding and autoimmunity. Tissue Antigens 59:78–87
Tomer Y (2010) Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 20:715–725
Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, Tomer Y (2005) Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab 90:4904–4911
Jacobson EM, Huber A, Tomer Y (2008) The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30:58–62
Menconi F, Monti MC, Greenberg DA et al (2008) Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci USA 105:14034–14039
Maciel LM, Rodrigues SS, Dibbern RS, Navarro PA, Donadi EA (2001) Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 11:31–35
Ban Y, Davies TF, Greenberg DA et al (2004) Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun 5:203–208
Hodge SE, Ban Y, Strug LJ et al (2006) Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease. Thyroid 16:351–355
Jacobson EM, Tomer Y (2007) The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 28:85–98
Tomer Y, Concepcion E, Greenberg DA (2002) A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12:1129–1135
Jacobson EM, Concepcion E, Oashi T, Tomer Y (2005) A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146:2684–2691
Khattri R, Auger JA, Griffin MD, Sharpe AH, Bluestone JA (1999) Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses. J Immunol 162:5784–5791
Ueda H, Howson JM, Esposito L et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506–511
Chung SA, Criswell LA (2007) PTPN22: its role in SLE and autoimmunity. Autoimmunity 40:582–590
Yang Y, Chung EK, Wu YL et al (2007) Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 80:1037–1054
Huber AK, Concepcion ES, Gandhi A, et al. (2010), Analysis of Immune Regulatory Genes' Copy Number Variants in Graves' Disease. Thyroid. Nov 8
Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y (2003) Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A 100:15119–15124
Tomer Y, Ban Y, Concepcion E et al (2003) Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 73:736–747
Brent GA (2010) Environmental exposures and autoimmune thyroid disease. Thyroid 20:755–761
Papanastasiou L, Vatalas L, Koutras DA, Mastorakos G (2007) Thyroid autoimmunity in the current iodine environment. Thyroid 17:729–739
Teng W, Shan Z, Teng X et al (2006) Effect of iodine intake on thyroid diseases in China. N Engl J Med 354:2783–2793
Doufas AG, Mastorakos G, Chatziioannou S et al (1999) The predominant form of non-toxic goiter in Greece is now autoimmune thyroiditis. Eur J Endocrinol 140:505–511
Kahaly GJ, Dienes HP, Beyer J, Hommel G (1998) Iodide induced thyroid autoimmunity in patients with endemic goiter: a randomized, double blind, placebo controlled trial. Eur J Endocrinol 139:290–297
Burek CL, Talor MV (2009) Environmental triggers of autoimmune thyroiditis. J Autoimmun 33:183–189
Tanda ML, Piatanida E, Lai A et al (2009) Thyroid autoimmunity and environment. Horm Metab Res 41:436–442
Bogazzi F, Bartalena L, Martino E (2010) Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 95:2529–2535
Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E (2001) The various effects of amiodarone on thyroid function. Thyroid 11:511–519
Pitsiavas V, Smerdely P, Li M, Boyages SC (1997) Amiodarone induces a different pattern of ultrastructural change in the thyroid to iodine excess alone in both the BB/W rat and the Wistar rat. Eur J Endocrinol 137:89–98
Wiersinga WM (2010) The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches. Heart Fail Rev 15:121–124
Shi RQ, Lee JK, Hayashi Y et al (2008) Long term amiodarone treatment causes cardioselective hypothyroid-like alteration in gene expression profile. Eur J Pharmacol 578:270–278
Chen F, Day SL, Metcalfe RA et al (2005) Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advances human immunodeficiency virus (HIV) disease. Medicine 84:98–106
Jubault V, Penfornis A, Schillo F et al (2000) Sequential occurrence of thyroid autoantibodies and Graves’ disease after immune restoration in severely immunocompromised human immunodeficiency virus-1 infected patients. J Clin Endocrinol Metab 85:4254–4257
Madeddu G, Spanu A, Chessa F et al (2006) Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study. Clin Endocrinol 64:375–383
Tomer Y, Menconi F (2009) Interferon induced thyroiditis. Best Pract Res Clin Endocrinol Metab 23:703–712
Mandac JC, Chaudhry S, Sherman KE, Tomer Y (2006) The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 43:661–672
Antonelli A, Ferri C, Pampana A et al (2004) Thyroid disorders in chronic hepatitis C. Am J Med 117:10–13
Tomer Y, Huber A (2009) The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 32:231–239
Desailloud R, Hober D (2009) Viruses and thyroiditis: an update. Virol J 6:5
Benvenga S, Santarpia L, Trimarchi F, Guarneri F (2006) Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid 16:225–236
Volzke H, Werner A, Guertler L, Robinson D, Wallaschofski H, John U (2005) Putative association between anti-Borrelia IgG and autoimmune thyroid disease? Thyroid 15:1273–1277
Prummel MF, Strieder T, Wiersinga WM (2004) The environment and autoimmune thyroid diseases. Eur J Endocrinol 150:605–618
Tomer Y, Villanueva R (2004) Hepatitis C and thyroid autoimmunity: is there a link? Am J Med 117:60–61
Ganne-Carrie MA, Coderc E et al (2000) Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case control study. J Autoimmun 14:189–193
Andrade LJ, Atta AM, D'Almeida Junior A, Paraná R (2008) Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin—a review. Braz J Infect Dis 12:144–148
Hsieh MC, Yu ML, Chuang WL et al (2000) Virologic factors related to interferon alpha induced thyroid dysfunction in patients with chronic hepatitis C. Eur J Endocrinol 142:431–437
Bartolome J (2008) Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J Med Virol 80:1588–1594
Akeno N, Blackard JT, Tomer Y (2008) HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun 31:339–344
Boas M, Main KM, Feldt-Rasmussen U (2009) Environmental chemicals and thyroid function: an update. Curr Opin Endocrinol Diab Obes 16:385–391
Bahn AK, Mills JL, Snyder PJ et al (1980) Hypothyroidism in workers exposed to polybrominated biphenyls. N Engl J Med 302:31–33
Moriyama K, Tagami T, Akamizu T et al (2002) Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 87:5185–5190
Jungel A, Ospelt C, Gay S (2010) What can we learn from epigenetics in the year 2009? Curr Opin Rheumatol 22:284–292
Barski A, Cuddapah S, Cui K et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129:823–837
Bell CG, Teschendorff AE, Rakyan VK, Maxwell AP, Beck S, Savage DA (2010) Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics 3:33
Heerwagen MJ, Miller MR, Barbour LA, Friedman JE (2010) Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol 299:R711–R722
Karouzakis E, Gay RE, Gay S, Neidhart M (2009) Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat Rev Rheumatol 5:266–272
Hewagama A, Richardson B (2009) The genetics and epigenetics of autoimmune diseases. J Autoimmun 33:3–11
Youngblood B, Reich NO (2008) The early expressed HIV-1 genes regulate DNMT1 expression. Epigenetics 3:149–156
Menconi F, Osman R, Monti MC, Greenberg DA, Concepcion ES, Tomer Y (2010) Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc Natl Acad Sci U S A 107:16899–16903
EM YH, Menconi F et al (2009) Employing a recombinant HLA-DR3 expression system to dissect MHC II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective. J Biol Chem 284:34231–34243
Acknowledgments
This work was supported in part by grants DK061659, DK067555, and DK073681 from NIDDK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eschler, D.C., Hasham, A. & Tomer, Y. Cutting Edge: The Etiology of Autoimmune Thyroid Diseases. Clinic Rev Allerg Immunol 41, 190–197 (2011). https://doi.org/10.1007/s12016-010-8245-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-010-8245-8